Clinical Trial

Efficacy of an Antioxidant Moisturizing Serum for Mild to Moderate Seborrheic Dermatitis

Study acronym: Pilot RCT
Completed
View on ClinicalTrials.gov →
Summary
This is a 4-week comparison study between the intervention and control sides of the face. Purposive sampling to recruit 13 patients with seborrheic dermatitis will be conducted in this study. The study will start after researcher has been granted the Ethic Committee Approval. The process of subject recruitment and clinical data collection will take place at the Outpatient Department (OPD) while photograph taking and skin measurement will take place at Laser Center and Bioengineering Department, respectively. All bioengineering instruments will be operated under the climate controlled environment; i.e, at temperature 20+/-2 degree Celsius and 50+/-2 % of relative humidity. A subject must get acclimatized to the ambient atmosphere for at least 30 minutes. The clinical data, skin barrier function, the quality of life, subject's satisfaction scale will be collected at the first day (D0, as baseline) and 4th week after finishing the test product (Wk4).
Protocol Amendment History 3 changes
critical Trial completed 2026-07-29
notable Primary completion pushed: 2026-05-01 -> 2026-06-30 2026-06-11
minor Completion moved earlier: 2026-08-01 -> 2026-07-01 2026-06-11
Trial Details
NCT Number NCT07433907
Lead Sponsor Institute of Dermatology, Thailand
Conditions Seborrheic Dermatitis on the Face
Enrollment 13 participants
Start Date 2026-03-06
Primary Completion 2026-07-07 (estimated)
Study Completion 2026-07-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-28